About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:4354165
Allelic
Composition
Srrrgsc1872/Srrrgsc1872
Genetic
Background
C57BL/6JJcl-Srrrgsc1872
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Srrrgsc1872 mutation (1 available); any Srr mutation (17 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
behavior/neurological
• in a spatial object recognition assay mice fail to spend more time investigating displaced objects relative to non-displaced objects unlike controls (J:151337)
• however, response to introduction of a novel object is similar to controls (J:151337)
• treatment with D-serine or clozapine improves performance (J:151337)
• in a spatial object recognition assay mice fail to spend more time investigating displaced objects relative to non-displaced objects unlike controls (J:151337)
• however, response to introduction of a novel object is similar to controls (J:151337)
• treatment with D-serine or clozapine improves performance (J:151337)
• impaired performance in a Morris water maze probe trial conducted 5 days after training (J:151337)
• impaired performance in a Morris water maze probe trial conducted 5 days after training (J:151337)
• hyperactivity induced by MJ-801 is significantly greater compared to controls (J:151337)
• hyperactivity induced by MJ-801 is significantly greater compared to controls (J:151337)
• mice do no prefer the chamber with an unfamiliar conspecific mouse over the empty chamber in a sociability assay (J:151337)
• but, mice perform normally in a social novelty assay and no defects in exploratory behavior or olfactory function were detected (J:151337)
• treatment with D-serine, but not with clozapine, reversed the social behavior defect (J:151337)
• mice do no prefer the chamber with an unfamiliar conspecific mouse over the empty chamber in a sociability assay (J:151337)
• but, mice perform normally in a social novelty assay and no defects in exploratory behavior or olfactory function were detected (J:151337)
• treatment with D-serine, but not with clozapine, reversed the social behavior defect (J:151337)

homeostasis/metabolism
• D-serine levels are markedly reduced in the whole brain, hippocampus, and frontal cortex, but not in the cerebellum (J:151337)
• in the frontal cortex L-serine levels are increased (J:151337)
• D-serine levels are markedly reduced in the whole brain, hippocampus, and frontal cortex, but not in the cerebellum (J:151337)
• in the frontal cortex L-serine levels are increased (J:151337)

nervous system
• decreased prepulse inhibition (J:151337)
• responses to startle stimuli are normal in the absence of prepulse signal (J:151337)
• treatment with D-serine or clozapine rescued the prepulse inhibition defect (J:151337)
• treatment with MK-801 induces a greater impairment in prepulse inhibition compared to similarly treated controls (J:151337)
• decreased prepulse inhibition (J:151337)
• responses to startle stimuli are normal in the absence of prepulse signal (J:151337)
• treatment with D-serine or clozapine rescued the prepulse inhibition defect (J:151337)
• treatment with MK-801 induces a greater impairment in prepulse inhibition compared to similarly treated controls (J:151337)

Mouse Models of Human Disease
OMIM ID Ref(s)
Schizophrenia; SCZD 181500 J:151337


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Tumor Biology (MTB), Gene Ontology (GO), MouseCyc
Citing These Resources
Funding Information
Warranty Disclaimer & Copyright Notice
Send questions and comments to User Support.
last database update
01/26/2016
MGI 6.02
The Jackson Laboratory